A Randomized, Double-Blind, Placebo Controlled Pilot Study to Determine the Safety and Efficacy of Ivacaftor (VX-770) for the Treatment of Chronic Obstructive Pulmonary Disease (The TOPIC Trial)

Trial Profile

A Randomized, Double-Blind, Placebo Controlled Pilot Study to Determine the Safety and Efficacy of Ivacaftor (VX-770) for the Treatment of Chronic Obstructive Pulmonary Disease (The TOPIC Trial)

Completed
Phase of Trial: Phase 0

Latest Information Update: 26 Feb 2017

At a glance

  • Drugs Ivacaftor (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms TOPIC
  • Most Recent Events

    • 01 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 May 2015 Planned End Date changed from 1 May 2015 to 1 May 2016, as reported by ClinicalTrials.gov.
    • 14 May 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top